US SEC Trading Suspension Halt Orders — April 21, 2026

21-04-2026

On April 17, 2026, Expensify, Inc. received a Nasdaq deficiency notice stating that its Class A common stock (EXFY) closed below the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5450(a)(1). The stock continues to trade on Nasdaq Global Select Market with no immediate delisting, but the company has 180 calendar days until October 14, 2026, to achieve $1.00 closing prices for 10 consecutive business days. Expensify plans to seek stockholder approval for reverse stock splits (1-for-15, 1-for-20, or 1-for-25) at its May 22, 2026 annual meeting, though compliance is not guaranteed and further extension would require transfer to Nasdaq Capital Market.

• ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period
• ·Potential transfer to Nasdaq Capital Market for additional 180 days if initial compliance fails
• ·Stockholders to vote on three alternative reverse stock split ratios at annual meeting

21-04-2026

On April 17, 2026, Atlantic American Corporation received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to failure to file its Form 10-K for the year ended December 31, 2025. The company has 60 calendar days to submit a plan to regain compliance, with potential extension up to 180 days from the 10-K due date if accepted by Nasdaq; failure could lead to appeal or delisting proceedings. There is no immediate impact on the listing of its common stock (AAME) on The Nasdaq Global Market, and the company is working to file the 10-K promptly.

• ·Nasdaq Listing Rule 5250(c)(1) requires timely filing of periodic financial reports with the SEC.
• ·Opportunity to appeal to a Nasdaq Hearings Panel if compliance plan is rejected.
• ·Press release issued on April 21, 2026, attached as Exhibit 99.1.

21-04-2026

Fly-E Group, Inc. received a Nasdaq deficiency letter on April 17, 2026, notifying failure to comply with Listing Rule 5620(a) by not holding an annual shareholder meeting within 12 months of its fiscal year ended March 31, 2025. The company has 45 days until June 1, 2026, to submit a compliance plan, potentially granting an extension until September 28, 2026; there is no immediate effect on listing or trading. While the delay was administrative and the company intends to hold the meeting promptly, compliance is not assured and could lead to further risks.

• ·Company CIK: 0001975940
• ·Commission File Number: 001-42122
• ·Fiscal Year End: March 31
• ·Trading Symbol: FLYE (Common stock, $0.01 par value per share) on Nasdaq Capital Market
• ·Principal Executive Offices: 136-40 39th Avenue, Suite 202, Flushing, New York 11354

21-04-2026

Allied Gaming & Entertainment Inc. received a Nasdaq deficiency letter on April 16, 2026, notifying non-compliance with Listing Rule 5250(c)(1) due to failure to file its Form 10-K for the fiscal year ended December 31, 2025, by the extended due date of April 15, 2026. The company has 60 days, until June 15, 2026, to submit a compliance plan and expects to file the 10-K prior to this deadline, though Nasdaq may grant an extension to October 12, 2026, with no assurance of acceptance or full compliance. There is no immediate effect on the listing or trading of its common stock (AGAE) on Nasdaq.

• ·Company filed Form 12b-25 on March 31, 2026, extending 10-K due date to April 15, 2026.
• ·Press release issued on April 21, 2026, in accordance with Nasdaq Listing Rule 5810(b), attached as Exhibit 99.1.

21-04-2026

Driven Brands provided preliminary unaudited results for Q4 and FY 2025 showing Driven SSS growth of 0.3%-0.5% (flat) in Q4 but 3.5%-3.7% for FY, with Take 5 SSS at 0.95%-1.0% Q4, 6.1%-6.2% FY, and 1.9%-2.1% / 4.3%-4.5% respectively in Q1 2026; revenue of $450-$460M Q4, $1,850-$1,860M FY2025, $475-$485M Q1 2026; and Adjusted EBITDA of $100-$110M Q4, $440-$450M FY (expected lower than prior year due to restatement expenses). The company reported net unit growth (Driven: 81 Q4/175 FY/29 Q1; Take 5: 60/161/29) and reduced net debt to ~$1.6B end Q1 2026 from $2.1B end FY2025. However, it disclosed delays in filing 2025 Form 10-K (now expected by June 15, 2026 compliance plan deadline) and Q1 2026 10-Q due to restatement of prior financials and material weaknesses in internal controls.

• ·Results exclude US and International Car Wash businesses (discontinued operations).
• ·Revolving credit facility and securitization variable funding notes currently undrawn.
• ·Nasdaq compliance plan due June 15, 2026 for delinquent 10-K; expects to file 2025 10-K by then.
• ·Material weaknesses identified in internal control over financial reporting and disclosure controls.
• ·Restatement impacts FY2024, FY2023, and certain 2025 quarterly periods.

21-04-2026

On April 20, 2026, Laser Photonics Corporation received a Nasdaq notice for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-K for the year ended December 31, 2025, triggering a potential delisting risk. The company promptly filed the overdue 10-K, and Nasdaq confirmed compliance and closed the matter on April 21, 2026. A related press release was issued on April 22, 2026.

• ·Company has 60 calendar days from notice (until June 22, 2026) to submit compliance plan if needed.
• ·Nasdaq could grant up to 180 calendar days exception from original due date (until October 12, 2026) for filing.
• ·Delay attributed to resolving accounting issues with newly engaged independent registered public accounting firm.

21-04-2026

Society Pass Incorporated received a delinquency notification from Nasdaq on April 16, 2026, for failing to timely file its Form 10-K for the fiscal year ended December 31, 2025, violating Listing Rule 5250(c)(1). The notice has no immediate effect on the company's Nasdaq listing (SOPA), but non-compliance could lead to delisting. The company has 60 days until June 15, 2026, to submit a compliance plan and expects to file the 10-K within that period, potentially avoiding further action.

• ·Nasdaq may grant up to 180 calendar days from the 10-K due date (until October 12, 2026) if compliance plan is accepted.
• ·Company issued required press release on April 21, 2026 (Exhibit 99.1).
• ·Emerging growth company status confirmed.

21-04-2026

ENDRA Life Sciences Inc. received a Nasdaq notice on April 20, 2026, indicating that its stockholders' equity of $2,260,120 as reported in its Form 10-K for the year ended December 31, 2025, falls below the $2,500,000 minimum required under Nasdaq Listing Rule 5550(b)(1), resulting in non-compliance and potential delisting. The company intends to request a hearing before the Nasdaq Hearings Panel, which would stay delisting pending a decision, and is evaluating options to regain compliance. No assurance exists that the company will succeed in regaining or maintaining compliance.

• ·Previous compliance: Regained on November 18, 2025, subject to ongoing monitoring after extension to November 24, 2025.
• ·Initial deficiency notice: May 27, 2025; compliance plan submitted July 11, 2025.
• ·Company address: 3600 Green Court, Suite 350, Ann Arbor, MI 48105.
• ·Trading symbol: NDRA on The Nasdaq Stock Market LLC; common stock par value $0.0001 per share.

21-04-2026

Aimei Health Technology Co., Ltd. received a Nasdaq notice on April 17, 2026, for non-compliance with Listing Rule 5250(c)(1) due to failure to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, due March 31, 2026, after submitting a late filing notification on Form 12b-25 on April 1, 2026. The notice has no immediate effect on trading but risks delisting if unresolved, with 60 days to file the report or submit a compliance plan, potentially extendable to 180 days. The Company expects to regain compliance but provides no assurances on timing.

• ·Notification of Late Filing on Form 12b-25 filed April 1, 2026
• ·Press release issued April 21, 2026 (Exhibit 99.1)
• ·Company is an emerging growth company